INS and type 2 diabetes mellitus: 1), purposely selected to capture ∼93% of common CACNA1E variability, in determining pathophysiological phenotypes (i.e. beta cell function and insulin sensitivity) in patients with newly diagnosed type 2 diabetes of the VNDS.